샘플 요청 목록

 카트 문의
시장보고서
상품코드
1780711

세계의 약제 코팅 풍선 카테터 시장

Drug-Coated Balloon Catheters
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 375 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 약제 코팅 풍선 카테터 시장은 2030년까지 21억 달러에 도달

2024년에 15억 달러로 추정되는 세계의 약제 코팅 풍선 카테터 시장은 2024-2030년의 분석 기간에 CAGR 6.0%로 성장하며, 2030년에는 21억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 Paclitaxel은 CAGR 4.9%를 기록하며, 분석 기간 종료시에는 13억 달러에 달할 것으로 예측됩니다. Sirolimus 분야의 성장률은 분석 기간 중 CAGR 8.0%로 추정됩니다.

미국 시장은 3억 9,580만 달러로 추정, 중국은 CAGR 9.2%로 성장할 것으로 예측

미국의 약제 코팅 풍선 카테터 시장은 2024년에 3억 9,580만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2024-2030년의 분석 기간에 CAGR 9.2%를 견인하며, 2030년에는 4억 1,490만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.0%와 5.8%로 예측됩니다. 유럽에서는 독일이 CAGR 3.9%로 성장할 것으로 예측됩니다.

세계의 ' 약제 코팅 풍선 카테터 ' 시장 - 주요 동향과 촉진요인 정리

약물 코팅 풍선 카테터가 심혈관 치료에서 주목받는 이유는?

약물 코팅 풍선(DCB) 카테터는 중재적 심장병학 및 혈관 수술의 판도를 바꾸고 있습니다. 기존 스텐트와 달리 DCB는 혈관벽에 직접 항증식제를 주입하여 영구적인 임플란트를 남기지 않고 재협착의 위험을 줄입니다. 이 장치는 관상동맥질환, 말초동맥질환(PAD), 스텐트내 재협착에 특히 유용하며, 합병증이 적은 보다 안전한 옵션을 제공합니다.

어떤 기술 발전이 DCB의 성능을 향상시키고 있는가?

폴리머가 없는 약물 코팅, 친수성 전달 시스템, 생분해성 캐리어의 획기적인 발전으로 표적 동맥에서 약물의 유지 및 흡수가 향상되었습니다. 파클리탁셀을 기반으로 한 DCB와 실로리무스를 코팅한 DCB의 개발로 부작용을 최소화하면서 치료 효과를 더 오래 지속시킬 수 있게 되었습니다. 카테터의 유연성, 약물의 정밀 투여, 영상 유도하 전개 등의 발전으로 시술의 성과는 더욱 향상되고 있습니다.

규제와 시장 수요는 채택에 어떤 영향을 미치고 있는가?

FDA 및 CE 마크 기관과 같은 규제기관은 심혈관 중재술 이외의 새로운 적응증에 대해 DCB를 승인하는 경향이 강화되고 있으며, 당뇨병성 혈관 합병증 및 동정맥루 치료에 대한 사용을 확대하고 있습니다. 또한 최소침습 수술 및 외래 수술 증가는 약제용출 스텐트(DES)를 대체할 수 있는 비용 효율적이고 효율적인 대안으로 DCB에 대한 수요를 증가시키고 있습니다.

시장 성장의 원동력은?

약물 코팅 풍선 카테터 시장의 성장은 심혈관 질환의 유병률 증가, 스텐트 없는 치료에 대한 선호도 증가, 약물전달 코팅의 발전으로 인해 촉진되고 있습니다. 인구 고령화, 외래 혈관성형술의 도입 확대, 신약 제제의 임상시험 진행 중 등도 시장 성장 촉진요인으로 작용하고 있습니다. 또한 비심혈관 치료에 대한 DCB의 적용 확대는 임상적 연관성과 상업적 가능성을 넓혀가고 있습니다.

부문

유형(Paclitaxel, Sirolimus); 제품(관상동맥 질환, 말초혈관 질환); 최종사용자(병원, 클리닉, 외래 수술 센터)

조사 대상 기업의 예

  • Abbott Laboratories
  • Alvimedica
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BD(Becton, Dickinson and Company)
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Eurocor GmbH
  • iVascular S.L.U.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • OrbusNeich Medical Group
  • QT Vascular Ltd.
  • Shockwave Medical, Inc.
  • Surmodics, Inc.
  • Terumo Corporation
  • TriReme Medical, LLC

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.07

Global Drug-Coated Balloon Catheters Market to Reach US$2.1 Billion by 2030

The global market for Drug-Coated Balloon Catheters estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Paclitaxel, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Sirolimus segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$395.8 Million While China is Forecast to Grow at 9.2% CAGR

The Drug-Coated Balloon Catheters market in the U.S. is estimated at US$395.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$414.9 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global "Drug-Coated Balloon Catheter" Market - Key Trends & Drivers Summarized

Why Are Drug-Coated Balloon Catheters Gaining Traction in Cardiovascular Care?

Drug-coated balloon (DCB) catheters have become a game-changer in interventional cardiology and vascular surgery. Unlike traditional stents, DCBs deliver antiproliferative drugs directly to vessel walls, reducing the risk of restenosis without leaving a permanent implant. These devices are particularly useful for coronary artery disease, peripheral artery disease (PAD), and in-stent restenosis, offering a safer alternative with fewer complications.

What Technological Advances Are Improving DCB Performance?

Breakthroughs in polymer-free drug coatings, hydrophilic delivery systems, and biodegradable carriers have enhanced drug retention and absorption in target arteries. The development of paclitaxel-based and sirolimus-coated DCBs has led to longer-lasting therapeutic effects with minimal side effects. Advances in catheter flexibility, precision drug dosing, and imaging-guided deployment have further improved procedural outcomes.

How Are Regulations and Market Demand Influencing Adoption?

Regulatory bodies like the FDA and CE Marking agencies are increasingly approving DCBs for new indications beyond cardiovascular interventions, expanding their use in diabetic vascular complications and arteriovenous fistula treatments. The rise in minimally invasive surgeries and outpatient procedures has also driven demand for DCBs as a cost-effective and efficient alternative to drug-eluting stents (DES).

What Is Propelling the Market Growth?

The growth in the Drug-Coated Balloon Catheter market is fueled by the rising prevalence of cardiovascular diseases, increasing preference for non-stent-based interventions, and advancements in drug delivery coatings. The aging population, growing adoption of outpatient angioplasty procedures, and ongoing clinical trials for new drug formulations are also key market drivers. Furthermore, the expansion of DCB applications into non-cardiac vascular treatments is broadening their clinical relevance and commercial potential.

SCOPE OF STUDY:

The report analyzes the Drug-Coated Balloon Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Paclitaxel, Sirolimus); Product (Coronary Artery Disease, Peripheral Vascular Disease); End-Use (Hospital, Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • Alvimedica
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BD (Becton, Dickinson and Company)
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Eurocor GmbH
  • iVascular S.L.U.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • OrbusNeich Medical Group
  • QT Vascular Ltd.
  • Shockwave Medical, Inc.
  • Surmodics, Inc.
  • Terumo Corporation
  • TriReme Medical, LLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Drug-Coated Balloon Catheters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Peripheral Artery Disease Propels Growth of Drug-Coated Balloon Catheters Market
    • Rising Geriatric Population Base Strengthens Business Case for Minimally Invasive Vascular Interventions
    • Shift Toward Endovascular Therapies Spurs Demand for Advanced Drug-Coated Balloon Technologies
    • Favorable Clinical Outcomes in Real-World Studies Drives Adoption Among Interventional Cardiologists
    • Increasing Healthcare Investments in Emerging Markets Expands Addressable Market Opportunity
    • Surge in Cardiovascular Disease Burden Across Asia-Pacific Accelerates Demand for Drug-Eluting Devices
    • Reimbursement Advancements in Europe and the U.S. Strengthen Market Accessibility and Uptake
    • Growing Focus on Limb Salvage in Critical Limb Ischemia Patients Drives Utilization of DCBs
    • Technological Innovations in Coating Materials and Drug Delivery Mechanisms Propel Product Differentiation
    • Regulatory Approvals and Fast-Track Designations in Key Markets Drive Commercial Launch Momentum
    • Increasing Clinical Trials and Data Transparency Strengthen Physician Confidence and Market Penetration
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Drug-Coated Balloon Catheters Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Drug-Coated Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Drug-Coated Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Paclitaxel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Paclitaxel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Paclitaxel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sirolimus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sirolimus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Sirolimus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Coronary Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Peripheral Vascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Peripheral Vascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Peripheral Vascular Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Drug-Coated Balloon Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Drug-Coated Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Spain 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Russia 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Australia 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 158: India Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: India 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: South Korea 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Drug-Coated Balloon Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Argentina 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Brazil 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Mexico 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Drug-Coated Balloon Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Iran 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Israel 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Saudi Arabia 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: UAE 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Rest of Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Africa 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제